The 2013 Korean Society of Hypertension guidelines outline risk-based treatment strategies for hypertension, allowing physician discretion for initial drug choice.
Supports risk-stratified antihypertensive care in practice; extends prior guidelines by endorsing flexible first-line drug selection.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Shin et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: